Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients

MLA

Joshua I. S. Bleier, et al. “Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.” Clinical Colorectal Cancer, vol. 18, Dec. 2019, pp. 292–300. EBSCOhost, https://doi.org/10.1016/j.clcc.2019.04.002.

APA

Joshua I. S. Bleier, Elias Chamely, Nicole M. Saur, Emily Carter Paulson, Richard T. Birkett, Seth J. Concors, Cary B. Aarons, & Skandan Shanmugan. (2019). Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients. Clinical Colorectal Cancer, 18, 292–300. https://doi.org/10.1016/j.clcc.2019.04.002

Chicago

Joshua I. S. Bleier, Elias Chamely, Nicole M. Saur, Emily Carter Paulson, Richard T. Birkett, Seth J. Concors, Cary B. Aarons, and Skandan Shanmugan. 2019. “Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.” Clinical Colorectal Cancer 18 (December): 292–300. doi:10.1016/j.clcc.2019.04.002.